Monoclonal antibody (mAb) drugs are a rapidly growing
class of biotherapeutics that target various diseases
including autoimmune disorders, cardiovascular diseases,
infectious diseases, and cancers.1
Recombinant mAbs are
subject to a variety of biochemical modifications during
processing, delivery, and storage.
United States
